Expert Comparison: Wegovy vs Mounjaro Mechanisms & Dosing
Understanding Which Is Better Wegovy or Mounjaro for Your Prescription Weight Loss Journey
When determining which is better Wegovy or Mounjaro for prescription weight loss, understanding the fundamental differences between these treatments is crucial. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. This means Mounjaro targets two hormonal pathways compared to Wegovy's single pathway approach. Both are prescription-only medicines that require clinical assessment and ongoing medical supervision.
The choice between these treatments often comes down to individual patient factors rather than one being universally superior. Wegovy has extensive clinical data from the STEP trial programme, showing average weight loss of approximately 15% when used alongside a reduced-calorie diet and increased physical activity. Mounjaro's SURMOUNT trials demonstrate different endpoints and populations, making direct comparison challenging. Your prescriber at EverydayMeds can evaluate your medical history, current medications, and weight loss goals to guide this decision.
Wegovy vs Mounjaro Pricing: Complete UK Cost Comparison
Understanding the cost implications when deciding which is better Wegovy or Mounjaro involves comparing both initial and maintenance pricing structures. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose at £209.99. Our Getting Started bundles provide convenient multi-dose packages, such as the Intro Duo (0.25mg & 0.5mg) for £169.99. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25.
Mounjaro follows a different pricing structure with its own dose escalation schedule, though both treatments require gradual dose increases for tolerability. When comparing long-term costs, consider that Wegovy maintenance occurs at 2.4mg weekly, whilst Mounjaro maintenance may differ. Our pharmacy team (GPhC #9012878) can provide detailed cost projections based on your expected treatment duration and dose requirements, helping you make an informed financial decision alongside clinical considerations.
Clinical Evidence: Which Is Better Wegovy or Mounjaro Based on Research?
The clinical evidence supporting both treatments comes from robust phase 3 trial programmes, though direct head-to-head comparisons don't exist. Wegovy's evidence base includes the comprehensive STEP trials, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, adding significant clinical value beyond weight management.
Mounjaro's SURMOUNT programme provides evidence for tirzepatide's efficacy, though comparing percentage weight loss between trials can be misleading due to different study designs, populations, and endpoints. Both treatments require use alongside lifestyle modifications, and individual responses vary significantly. Your prescriber will consider your medical history, co-existing conditions, and treatment goals when determining which option may be more suitable for your circumstances.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines after eating. This mechanism reduces appetite by acting on brain appetite centres, particularly in the hypothalamus, creating feelings of satiety with smaller meal portions. The medication also slows gastric emptying, meaning food remains in your stomach longer, contributing to prolonged fullness. Additionally, Wegovy may help reduce food cravings and the psychological drive to eat, though individual responses vary. This comprehensive approach to appetite regulation explains why the medication must be combined with dietary modifications and increased physical activity for optimal results.
Ordering Process: Getting Your Wegovy or Mounjaro Prescription
Starting your prescription weight loss journey with either Wegovy or Mounjaro through EverydayMeds involves a streamlined three-step process designed for convenience and safety. First, complete our comprehensive 3-minute online clinical assessment, providing detailed information about your medical history, current medications, weight loss goals, and any previous treatment experiences. Next, our qualified prescribers review your assessment, typically within 3 working days (or 24 hours with express service), determining suitability and recommending the most appropriate treatment option. Finally, once approved, your medication ships via next-day cold-chain delivery, maintaining the temperature-controlled storage requirements essential for these biological medicines.
Storage and Practical Considerations: Wegovy vs Mounjaro Convenience
When considering which is better Wegovy or Mounjaro for practical daily use, storage requirements present a significant differentiator. Wegovy offers superior storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature stability makes it more travel-friendly and convenient for busy lifestyles. The FlexTouch pen delivery system used by Wegovy is pre-filled and disposable, requiring no mixing or preparation. Dose escalation follows a structured 16-week schedule, starting at 0.25mg and increasing every 4 weeks until reaching the 2.4mg maintenance dose.
Prescription Weight Loss: Personalised Treatment Selection
The question of which is better Wegovy or Mounjaro for prescription weight loss cannot be answered universally, as individual patient factors significantly influence treatment success. Your medical history, including diabetes status, cardiovascular risk factors, gastrointestinal tolerance, and previous weight loss attempts, all inform prescriber recommendations. Some patients may respond better to Wegovy's single GLP-1 pathway, whilst others might benefit from Mounjaro's dual mechanism approach.
Additionally, practical considerations such as injection frequency preferences, storage requirements, travel needs, and long-term cost considerations vary between individuals. At EverydayMeds, our prescribers evaluate these multiple factors comprehensively, ensuring your treatment choice aligns with both clinical appropriateness and lifestyle compatibility for sustained weight management success.
Making Your Decision: Expert Support from EverydayMeds
Rather than determining which is better Wegovy or Mounjaro in isolation, our approach focuses on matching the right treatment to your individual circumstances and goals. Both medications are available through our GPhC-registered pharmacy (#9012878), with comprehensive prescriber support throughout your weight management journey. New customers can begin their assessment today using discount code FIRST40, whilst returning patients benefit from DOSE25 savings. Our clinical team provides ongoing monitoring, dose adjustment guidance, and lifestyle support to maximise your treatment success. Visit https://everydaymeds.co.uk/collections/wegovy to start your personalised assessment and receive expert guidance on selecting the most appropriate prescription weight loss treatment for your needs.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
